Fulgent Genetics Inc reports results for the quarter ended in September - Earnings Summary

Fulgent Genetics

07/11/2022 22:50

* Fulgent Genetics Inc  FLGT.OQ  reported quarterly adjusted
earnings of 32 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for earnings of 5 cents per share.
    * Revenue fell 53.6% to $105.66 million from a year ago;
analysts
expected $91.36 million. 
    * Fulgent Genetics Inc's reported EPS for the quarter was 6
cents​.
    * The mean earnings estimate of analysts had fallen by
about 82.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Fulgent Genetics Inc shares had fallen by 0.4% this
quarter and
lost 62.2% so far this year.
    * The company reported quarterly net income of $1.72
million.
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $67.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
7 at 10:50 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.05           0.32           Beat
 Jun. 30 2022      0.73           0.78           Beat
 Mar. 31 2022      3.86           5.08           Beat
 Dec. 31 2021      2.61           3.34           Beat